New eye drop tested for debilitating dry eye in transplant patients
NCT ID NCT06495307
Summary
This early-stage study tested a new eye drop called rhPRG4 for people with severe dry eye caused by graft-versus-host disease, a complication of bone marrow transplants. The goal was to see if the eye drop was safe and could relieve symptoms like dryness, pain, and blurred vision. The study was small and ended early, so it was mainly a first step to gather initial safety information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OTA
Brisbane, Queensland, Australia
-
Sydney Eye Hospital
Sydney, New South Wales, Australia
Conditions
Explore the condition pages connected to this study.